Co-infection with Mycobacterium tuberculosis and HIV in high risk clinical care settings in Rhode Island

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 10, Issue 2, 1998, Pages 221-229

  Gampper, S N R ^a   George, J A ^a   Carter, E J ^b   Jesdale, B M ^a   Flanigan, T P ^c,e   Mayer, K H ^d,e   De Groot, A S ^a,b,e  

^a BROWN UNIVERSITY   (United States)

^b ROGER WILLIAMS MEDICAL CENTER   (United States)

^c MIRIAM HOSPITAL   (United States)

^d MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMORBIDITY; DATA BASE; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOBACTERIUM TUBERCULOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUBERCULOSIS; UNITED STATES;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; RHODE ISLAND; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0031954439     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540129850124479     Document Type: Article

References (23)

1. ALLAND, D., KALKUT, G.E., MOSS, A.R. ET AL. (1994). Transmission of tuberculosis in New York City. New England Journal of Medicine, 330, 1710-1716.
2. BRUDNEY, K. & DOBKIN, J. (1991). Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. American Review of Respiratory Disease, 144, 745-749.
3. CENTERS FOR DISEASE CONTROL AND PREVENTION (1989a). A strategic plan for the elimination of tuberculosis in the United States. Morbidity and Mortality Weekly Report, 38(S3), 1-25.
4. CENTERS FOR DISEASE CONTROL AND PREVENTION (1989b). Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). Morbidity and Mortality Weekly Report, 38, 236-238 and 243-250. CENTERS FOR DISEASE CONTROL AND PREVENTION (1990). Screening for tuberculosis and tuberculosis infection in high risk populations and the use of preventive therapy for tuberculosis infection in the United States. Morbidity and Mortality Weekly Report, 39(RR-8), 1-12.
5. CENTERS FOR DISEASE CONTROL AND PREVENTION (1989b). Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). Morbidity and Mortality Weekly Report, 38, 236-238 and 243-250. CENTERS FOR DISEASE CONTROL AND PREVENTION (1990). Screening for tuberculosis and tuberculosis infection in high risk populations and the use of preventive therapy for tuberculosis infection in the United States. Morbidity and Mortality Weekly Report, 39(RR-8), 1-12.
6. CENTERS FOR DISEASE CONTROL AND PREVENTION (1991a) Nosocomial transmission of multidrug resistant tuberculosis among HIV infected persons - Florida and New York, 1988-1991. Morbidity and Mortality Weekly Report, 40, 585-591.
7. CENTERS FOR DISEASE CONTROL AND PREVENTION (1991b). Purified protein derivative (PPD)-tuberculin and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis infection. Morbidity and Mortality Weekly Report, 40, 27-33.
8. CENTERS FOR DISEASE CONTROL AND PREVENTION (1992). 1993 Revised classification system for HIV infection and the expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41, 1-10.
9. CENTERS FOR DISEASE CONTROL AND PREVENTION (1993). Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis. Morbidity and Mortality Weekly Report, 42(RR-7), 1-8.
10. CENTERS FOR DISEASE CONTROL AND PREVENTION (1994). Expanded tuberculosis surveillance and tuberculosis morbidity-United States, 1993. Morbidity and Mortality Weekly Report, 43(RR-13), 1-32.
11. DALEY, C.L., SMALL, P.M., SCHECHTER, G.F. ET AL. (1992). An outbreak of tuberculosis with accelerated progression among persons affected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. New England Journal of Medicine, 326, 231-235.
12. FRIEDEN, T.R., FUJIWARA, P.I., WASHKO, R.M. & HAMBURG, M.A. (1995). Tuberculosis in New York City - turning the tide. New England Journal of Medicine, 333(4), 229-233.
13. FRIEDEN, T.R., STERLING, T., PABLOS-MENDEZ, A. ET AL. (1993). The emergence of drug resistance in New York City. New England Journal of Medicine, 328, 521-526.
14. GREENBERG, B.L., WEISFUSE, I.B., MAKKI, H., ADLER, J., EL-SADR, W., CLARKE, L., GAINEY, S., ALFORD, T., MCFARLANE, K. & THOMAS, P. (1994). HIV-1 seroprevalence in chest clinic and hospital tuberculosis patients in New York City, 1989-1991. AIDS, 8(7), 957-962.
15. KLEINBAUM, D.G., KUPPER, L.L. & MORGENSTERN, H. (1982). Epidemiologic research principles and quantitative methods. Belmont, CA: Lifetime Learning Publications.
16. MURRAY, J.F. (1989). The white plague: down and out, or up and coming? American Review of Respiratory Disease, 140, 1788-1795.
17. SELWYN, P.A., HARTEL, D., LEWIS, V.A. ET AL. (1989). A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New England Journal of Medicine, 320, 545-550.
18. SMALL, P.M., HOPEWELL, P.C., SINGH, S.P. ET AL. (1994). The epidemiology of tuberculosis in San Francisco. New England Journal of Medicine, 330, 1703-1709.
19. SMALL, P.M., SCHECHTER, G.F., GOODMAN, P.C., SNADE, M.A., CHAISSON, R.E. & HOPEWELL, P.C. (1991). Treatment of tuberculosis in patients with advanced immunodeficiency virus infection. New England Journal of Medicine, 324, 289-294.
20. SMALL, P.M., SHAFER, R.W., HOPEWELL, P.C. ET AL. (1993). Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. New England Journal of Medicine, 328, 1137-1144.
21. VALWAY, S.E., RICHARDS, S.B., KOVACOVICH, J. ET AL. (1994). Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. American Journal of Epidemiology, 140(2), 113-122.
22. WADHAWAN, D., HIRA, S., MWANSA, N., SUNKUTU, R., ADERA, P. & PERINE, P. (1993). Preventive tuberculosis chemotherapy with isoniazid (INH) among patients infected with HIV-1. Ninth International Conference on AIDS in affiliation with the Fourth STD World Congress, Berlin, June 6-11, abstr PO-B07-1114.
23. WHALEN, C., HORSBURGH, C.R., HOM, D. ET AL. (1995). Accelerated course of human immunodeficiency virus infection after tuberculosis. American Journal of Respiratory and Critical Care Medicine, 151, 129-135.